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           Eosinophils mainly reside in the gastrointesti-
nal mucosa and normally constitute only 1  –  5% 
of blood nucleated cells. Eosinophils play an 
important role in host defense against parasitic 
infections and are major eff  ectors in a variety of 
allergic reactions (  1, 2  ). Upon diverse stimuli, 
infi  ltrating eosinophils cause chronic infl  amma-
tory tissue damage by releasing a wide spectrum 
of proinfl  ammatory mediators, including major 
basic protein, eosinophil cationic protein, and 
eosinophil-derived neurotoxin (  2, 3  ). 
  Like other hematopoietic lineages, eosino-
phils originate from the hematopoietic stem cell 
(HSC). In mouse hematopoiesis, the eosinophil 
lineage-committed progenitor (EoP) (  4  ) exists 
as a distinct population downstream of the 
granulocyte/macrophage progenitor (GMP) (  5  ). 
The mEoP expressed the receptor for IL-5 that 
plays an important role in controlling eosino-
phil numbers (  6  –  8  ). The mouse bipotent ba-
sophil/mast cell progenitor and the basophil 
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  To establish effective therapeutic strategies for eosinophil-related disorders, it is critical to 
understand the developmental pathway of human eosinophils. In mouse hematopoiesis, 
eosinophils originate from the eosinophil lineage-committed progenitor (EoP) that has been 
purifi  ed downstream of the granulocyte/macrophage progenitor (GMP). We show that the 
EoP is also isolatable in human adult bone marrow. The previously defi  ned human common 
myeloid progenitor (hCMP) population (Manz, M.G., T. Miyamoto, K. Akashi, and I.L. Weissman. 
2002.   Proc. Natl. Acad. Sci. USA.   99:11872  –  11877) was composed of the interleukin 
5 receptor      chain  +   (IL-5R      +  ) and IL-5R            fractions, and the former was the hEoP. The IL-
5R      +  CD34  +  CD38  +  IL-3R      +  CD45RA        hEoPs gave rise exclusively to pure eosinophil colonies 
but never differentiated into basophils or neutrophils. The IL-5R            hCMP generated the 
hEoP together with the hGMP or the human megakaryocyte/erythrocyte progenitor (hMEP), 
whereas hGMPs or hMEPs never differentiated into eosinophils. Importantly, the number of 
hEoPs increased up to 20% of the conventional hCMP population in the bone marrow of 
patients with eosinophilia, suggesting that the hEoP stage is involved in eosinophil differen-
tiation and expansion in vivo. Accordingly, the phenotypic defi  nition of hCMP should be 
revised to exclude the hEoP; an   “  IL-5R      –  negative  ”   criterion should be added to defi  ne more 
homogenous hCMP. The newly identifi  ed hEoP is a powerful tool in studying pathogenesis of 
eosinophilia and could be a therapeutic target for a variety of eosinophil-related disorders. 
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after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
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MNCs were basophils (  Fig. 1 A  ). The purity of sorted popu-
lations was   >  99% in all of these fractions. 
    Fig. 1 B   shows the expression patterns of cell-surface 
molecules related to the eosinophil and/or the basophil/mast 
cell lineages. CC chemokine receptor 3 (CCR3), a high-affi   nity 
receptor for eotaxin that promotes the migration of eosino-
phils and basophils into the infl  ammatory tissue (  16, 17  ), was 
expressed on both purifi  ed eosinophils and basophils.     7 
integrin is an essential molecule for tissue-specifi  c homing 
of precursors for mouse intestinal mast cells (  18  ), and is 
expressed on mouse mast cells and basophils but not on eo-
sinophils (  9, 19  ). In human blood, however, not only baso-
phils but also eosinophils expressed     7 integrin. CD203c, 
the ectonucleotide pyrophosphatase/phosphodiesterase 3, is 
reported to be a marker for human basophils, mast cells, and 
their precursors (  20  ). In our hands, however, CD203c was 
expressed on not only basophils but also eosinophils, indicat-
ing that this molecule is not specifi  c for the basophil/mast cell 
lineage. Thus, none of these markers appeared to be useful to 
diff  erentiate human eosinophils from basophils on FACS, ex-
cept for a high-affi   nity receptor for IgE      chain (Fc    RI    ) 
that was expressed only on human basophils (  Fig. 1 B  ). 
  We further tested the gene expression of lineage-specifi  c 
markers in each FACS-purifi  ed granulocyte subclass. The ex-
pression of myeloperoxidase (MPO), eosinophil peroxidase 
(EPX), and histidine decarboxylase (HDC) transcripts was eval-
uated. As shown in   Fig. 1 C  , human neutrophils exclusively 
possessed MPO but lacked the expression of EPX or HDC. 
Human eosinophils and basophils did not express MPO but 
possessed only EPX and HDC, respectively. Thus, in addition 
to the morphological analysis, the evaluation of these func-
tional molecules should be useful to diff  erentiate eosinophils 
from basophils and neutrophils. 
  Eosinophils develop from hHSCs and hCMPs but not 
from hGMPs or hMEPs 
  To delineate the developmental origin of human eosinophils, 
we tested the eosinophil lineage readout of myeloid progeni-
tor populations in steady-state bone marrow. As shown in 
  Fig. 2 A  , the lineage-affi   liated antigen (Lin       ) and CD34  +   human 
bone marrow MNC fraction was subdivided into the CD38        
hHSC and the CD38  +   progenitor populations (  21  ).   The 
Lin       CD34  +  CD38  +   human progenitors were further fraction-
ated into hCMP, hGMP, and hMEP populations according to 
the expression patterns of IL-3R     and CD45RA, as we previ-
ously reported (  15  ): hCMPs, hGMPs, and hMEPs were visual-
ized as the IL-3R      +  CD45RA       , IL-3R      +  CD45RA  +  , and 
IL-3R           CD45RA        populations, respectively (  Fig. 2 A  ). In 
liquid cultures supplemented with a cytokine cocktail con-
taining stem cell factor (SCF), IL-3, IL-5, GM-CSF, erythro-
poietin (Epo), and thrombopoietin (Tpo), hHSCs and hCMPs 
generated CCR3-expressing eosinophils/basophils as well as 
other myelomonocytic and MegE cells, whereas hGMPs and 
hMEPs gave rise mainly to neutrophils/monocytes/macro-
phages and MegE cells, respectively, without developing into 
the eosinophil lineage (  Fig. 2 B  ). Basophils were also scattered 
lineage-committed progenitor (BaP) were also identifi  ed 
downstream of the mGMP (  9  ), suggesting that the commit-
ment of eosinophil and basophil/mast cell lineages indepen-
dently occurs after the multipotent progenitor (MPP) has lost a 
megakaryocyte/erythroid (MegE) lineage potential. In con-
trast, in human hematopoiesis, cells possessing both basophil 
and eosinophil granules have been found in leukemia patients 
(  10, 11  ), suggesting the close relationship between the basophil 
and the eosinophil lineages. The early works using methylcel-
lulose colony assays of human bone marrow cells demonstrated 
that eosinophils were scattered preferentially within erythroid 
(  12  ) or myeloid (  13  ) colonies. These data raise the possibility 
that the eosinophil developmental pathway is considerably 
diff  erent between the human and mouse. However, such 
retrospective assessments of progenitor functions based on 
lineage readouts in colony assays does not necessarily refl  ect 
their full lineage potential because MPPs could decide lin-
eage fates in a random manner, at least in vitro (  14  ). 
  In this paper, we identifi  ed the EoP in human bone mar-
row. The previously defi  ned human common myeloid pro-
genitor (hCMP) (  15  ) was divided into the IL-5R      chain  +   
(IL-5R      +  ) and IL-5R            fractions, and the former was fully 
committed to the eosinophil lineage lacking the MegE, the 
neutrophil/monocyte, and the basophil/mast cell potentials. 
The hEoP was generated from the IL-5R            hCMP but not 
from the hGMP or the human megakaryocyte/erythrocyte 
progenitor (hMEP). Thus, the prospectively purifi  ed hEoP 
represents the initial stage of eosinophil development inde-
pendent of the hGMP, the hMEP, the putative human baso-
phil/mast cell progenitor, or the hBaP. Interestingly, the 
hEoP population expanded signifi  cantly in the bone marrow 
of patients with eosinophilia, suggesting that the hEoP might 
be a promising therapeutic target for eosinophil-related aller-
gic and infl  ammatory disorders. These data led us to revise our 
original defi  nition of the hCMP population by using   “  IL-
5R    -negative  ”   as an additional phenotypic criterion. 
    RESULTS   
  Three granulocyte subclasses such as neutrophils, 
eosinophils, and basophils can be purifi  ed 
from human blood by FACS 
  Isolation of a lineage-committed progenitor population by 
FACS is highly dependent on lineage-specifi  c surface mark-
ers. In mouse hematopoiesis, eosinophils but not basophils or 
neutrophils possessed a high level of IL-5R    , and the expres-
sion of IL-5R     was a key to isolate the mEoP (  4  ). We fi  rst 
tested the expression of IL-5R     on human blood leukocytes 
and found that both eosinophils and basophils expressed IL-
5R     at high levels. We further found that eosinophils and 
basophils independently resided within the polymorphonu-
clear cell (PMN) gate and the mononuclear cell (MNC) gate, 
respectively (  Fig. 1 A  ).   Thus, by combinatory analysis of the 
expression pattern of IL-5R     and of the forward scatter ver-
sus the side scatter cytogram, three classes of human blood 
granulocytes became clearly visible: IL-5R            PMNs were 
neutrophils, IL-5R     PMNs were eosinophils, and IL-5R     JEM VOL. 206, January 19, 2009 
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    Figure 1.         Purifi  cation of neutrophils, eosinophils, and basophils.   (A) Sorting gates for three granulocyte subclasses. The representative FACS plots of 
normal blood leukocytes are shown. IL-5R          and  IL-5R   +   fractions within the PMN gate were neutrophils (Neu) and eosinophils (Eo), respectively. Basophils 
(Ba) resided within the MNC gate and expressed IL-5R     at a high level. The purity of each sorted population was   >  99%, as determined morphologically by 
cytospin preparations (May-Giemsa staining). Bars, 10   μ  m. (B) FACS analyses of cell-surface molecules that relate to the eosinophil and/or the basophil lineages 
on each granulocyte subclass (percentages are shown). (C) RT-PCR analyses of lineage-affi  liated gene expression in FACS-purifi  ed granulocyte subclasses 
(whole, whole blood leukocytes). Data were reproducible in two independent analyses using different blood samples. FSC, forward scatter; SSC, side scatter.    
in the progeny of hHSCs, hCMPs, and hGMPs but not of 
hMEPs (unpublished data). In agreement with FACS and 
morphological analyses, progeny of hHSCs and hCMPs ex-
pressed both the eosinophil-affi   liated EPX and the basophil-
affi   liated HDC transcripts in addition to the MPO transcript, 
whereas progeny of hGMPs or hMEPs did not express EPX 186 IDENTIFICATION OF THE HUMAN EOSINOPHIL PROGENITOR   | Mori et al. 
IL-5R     was detectable only in the hCMP fraction:     10% of 
hCMPs expressed IL-5R     (  Fig. 3 A  ).   The IL-5R      +   fraction 
of hCMPs also expressed very low levels of CCR3 and     7 in-
tegrin (not depicted) that were detected on blood mature eo-
sinophils and basophils at high levels (  Fig. 1 B  ). Fc    RI     was 
specifi  cally expressed on blood basophils (  Fig. 1 B  ) but not 
detected in the hCMP population (not depicted). Strikingly, 
in methylcellulose assays, purifi  ed IL-5R      +   hCMPs gave rise 
only to pure eosinophil colonies (  Fig. 3, B and C  ). In con-
trast, the IL-5R            fraction of hCMPs generated a variety of 
myeloid colonies including rare (   2%) eosinophil-containing 
colonies (  Fig. 3 B  ). In liquid cultures, the day 14 progeny of 
IL-5R      +   hCMPs signifi  cantly up-regulated CCR3 on their 
surface (  Fig. 3 D  ). These cells possessed EPX but not MPO 
or HDC transcripts, whereas progeny of IL-5R            hCMPs 
(  Fig. 2 C  ). The HDC transcript was also detected in progeny 
of hGMPs but not of hMEPs (  Fig. 2 C  ). We further per-
formed methylcellulose assays, where we picked up all single 
colonies and made cytospin preparations to morphologi-
cally defi  ne cell components. As shown in   Fig. 2 D  ,     3% 
of hHSC- and     5% of hCMP-derived colonies contained 
eosinophils. hGMPs and hMEPs never generated eosinophil-
containing colonies. More interestingly,     4% of hCMP 
colonies were composed only of eosinophils (  Fig. 2 D  ), sug-
gesting that a fraction of cells within the hCMP gate may be 
progenitors already restricted to the eosinophil lineage. 
  The IL-5R      +   fraction within the original hCMP is the hEoP 
  To separate the putative hEoP, we tested the expression of IL-
5R     in stem and progenitor populations. The expression of 
    Figure 2.         Eosinophils develop from hHSCs and hCMPs but not from hGMPs or hMEPs.   (A) Sorting gates for hHSC and downstream myeloid pro-
genitor populations. (B) The emergence of CCR3  +   eosinophils in cultures of FACS-purifi  ed progenitor populations. A cytokine cocktail used in this experi-
ment contained SCF, IL-3, IL-5, GM-CSF, Epo, and Tpo. CCR3  +   eosinophils were detected in hHSC and hCMP cultures but not in hGMP or hMEP cultures. 
Dashed lines indicate cut-off lines of negative controls. (C) RT-PCR analyses of lineage-affi  liated gene expression in the progeny of each progenitor popu-
lation. The expression of eosinophil-specifi  c EPX was detected in progeny of hHSCs and hCMPs but not of hGMPs or hMEPs. (D) The methylcellulose col-
ony assays of FACS-purifi  ed progenitor populations. The eosinophil-containing (Eo-containing) colonies developed from hHSCs and hCMPs but not from 
hGMPs or hMEPs. Approximately 4% of hCMP-derived colonies were composed only of eosinophils (CFU-Eo). Data were reproducible in two independent 
experiments using different bone marrow samples.     JEM VOL. 206, January 19, 2009 
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gence of hEoPs within the culture of IL-5R            hCMPs 
and other myeloid progenitors. The hCMPs gave rise to a 
minor fraction of progeny expressing IL-5R     on day 5 
(  Fig. 4 A ), together with hGMPs and hMEPs (not depicted).  
The IL-5R      +   progeny gave rise exclusively to pure eosin-
ophil colonies (  Fig. 4 B  ), and they possessed the surface 
phenotype identical to that of hEoPs (  Fig. 4 C  ). Neither 
hGMPs nor hMEPs generated hEoPs at any time point dur-
ing the culture (unpublished data). These data strongly sug-
gest that the hEoPs develop from IL-5R            hCMPs but not 
from hGMPs. 
  Consistent with their capability of functional readouts, 
IL-5R     and EPX transcripts were exclusively expressed in 
hEoPs, whereas other eosinophil-specifi  c genes such as Char-
cot-Leyden crystal protein and major basic protein were 
expressed all of these molecules (  Fig. 3 E  ), supporting the eo-
sinophil lineage-restricted potential of the IL-5R      +   hCMP 
population. These observations collectively suggest that the 
IL-5R      +   fraction of original hCMP has committed to the 
eosinophil lineage. Thus, the hEoP was as isolatable as the 
IL-5R      +  hCD34  +  hCD38  +  IL-3R      +  hCD45RA        population 
in steady-state human bone marrow. These data also in turn 
show that the original hCMP (  15  ) includes the hEoP contami-
nant, and that its phenotypic defi  nition should be revised as 
IL-5R           hCD34  +  hCD38  +  IL-3R      +  hCD45RA       . 
  hEoPs develop from hCMPs independent of hGMPs 
and hMEPs 
  The question was of the lineage relationship between hEoPs 
and other myeloid progenitors. We tried to track the emer-
    Figure 3.         The IL-5R      +   fraction within the original hCMP represents the hEoP.   (A) FACS analysis of IL-5R     expression on myeloid progenitor pop-
ulations. The representative FACS plots of normal bone marrow progenitors are shown. (B) The methylcellulose colony assays of IL-5R          and  IL-5R   +  
fractions within the hCMP. The cytokine cocktail used in this experiment was the same as in   Fig. 2 B  . All of the single colonies were picked up and 
mounted on cytospin preparations to defi  ne cell components. The IL-5R    +   fraction of hCMP only generated pure eosinophil colonies (CFU-Eo). (C) The 
morphologies of purifi  ed hEoPs and their progeny. hEoPs represented a blastic morphology with fi  ne cytoplasmic granules (left), and their progeny were 
composed only of eosinophils (right; May-Giemsa staining). Bars, 10   μ  m. (D) FACS analysis of CCR3 expression on the progeny of IL-5R          hCMPs  and 
hEoPs. Dashed lines indicate cut-off lines of negative controls. (E) RT-PCR analyses of lineage-affi  liated gene expression in progeny of IL-5R          hCMPs 
and hEoPs. The progeny of hEoPs expressed a high level of EPX but never possessed MPO or HDC transcripts. Data were reproducible in two independent 
experiments using different bone marrow samples.     188 IDENTIFICATION OF THE HUMAN EOSINOPHIL PROGENITOR   | Mori et al. 
than that of hMEPs, whereas the GATA-2 level in hEoPs 
was higher than that in hMEPs (  Fig. 5 B  ). Friend of GATA-1 
(FOG-1) is a critical cofactor of GATA family transcription 
factors and plays an indispensable role in the mouse MegE 
lineage development (  26, 27  ), whereas it antagonizes the eo-
sinophil development presumably interfering with eosinophil 
lineage-related functions of GATA factors (  28  ). Consistent 
with these mouse data, hEoPs signifi  cantly down-regulated 
the FOG-1 expression, whereas hMEPs expressed FOG-1 at 
the highest level (  Fig. 5 B  ). The distribution of these GATA 
family transcription factors in human myeloid progenitors 
was identical to that in mouse counterparts (  29  ). 
  C/EBP     is required for the development of mGMPs as 
well as their progeny, including eosinophils (  30  ). In our hands, 
in mouse hematopoiesis, the eosinophil lineage commitment 
can be activated by up-regulation of GATA-2 in the pres-
ence of C/EBP     (  29  ). As shown in   Fig. 5 B  , the expression 
level of C/EBP     was highest in hGMPs but was diminished 
in hMEPs. Importantly, hCMPs, which are immediate pre-
cursors of hEoPs, possessed a signifi  cant amount of C/EBP    , 
and hEoPs maintained its expression with up-regulation of 
GATA-1 and GATA-2. PU.1 is indispensable for mouse granu-
locyte and lymphoid cell development (  31, 32  ). The expres-
sion of PU.1 was detected in both hGMPs and hEoPs but 
was suppressed at the hMEP stage. 
  These data show that changes in expression patterns of 
lineage-instructive transcription factors in these myeloid pro-
genitors are similar between human and mouse hematopoiesis 
(  29  ). Therefore, the developmental machinery of eosinophil 
lineage might be well preserved between these species. 
  The hEoP population signifi  cantly expanded in patients 
with eosinophilia 
  To evaluate whether the hEoP contributes toward eosino-
phil production in vivo, we enumerated the number of hE-
oPs in the bone marrow of eosinophilia patients. Patients  ’   
characteristics are summarized in   Table I  .   In normal bone 
marrow samples, the hEoP population accounted for only 
0.033% of bone marrow MNCs or 2.38% of Lin       CD34  +   
cells, respectively (  Table I   and   Fig. 6 A  ).   We analyzed 15 
patients with eosinophilia: 5 patients with hypereosinophilic 
syndrome (HES), 2 patients with T cell malignancies, 1 
chronic myelogenous leukemia patient in accelerated phase, 
2 patients with Churg-Strauss syndrome, and 5 eosinophilia 
patients with unknown etiology. The   FIP1L1/PDGFR       
fusion gene was not detected in any of these patients. The 
blood eosinophil count was 13,799   μ  l, and eosinophil lin-
eage cells accounted for 38.4% of whole bone marrow cells 
on average (  Table I  ). The bone marrow hEoP in eosino-
philia patients consisted of 0.125% of MNCs or 7.44% of 
Lin       CD34  +   cells, respectively (  Table I   and   Fig. 6 A  ). Thus, 
eosinophilia patients possessed three- to fourfold higher 
numbers of hEoPs compared with normal controls (P   <   0.01; 
  Fig. 6 A  ). These data suggest that the hEoP stage is ac-
tively involved in generation of eosinophils in patients 
with eosinophilia. 
expressed at low levels in hCMPs but were up-regulated at 
the hEoP stage (  Fig. 5 A  ).   hMEPs and hGMPs never ex-
pressed any of these eosinophil-related molecules (  Fig. 5 A  ). 
  Expression profi  les of lineage-instructive transcription 
factors in hEoPs 
  In mouse hematopoiesis, GATA-1 and GATA-2 play critical 
roles in the eosinophil lineage development. GATA-1  –  defi  -
cient mice lack eosinophils (  22, 23  ), and the enforced expres-
sion of GATA-1 or GATA-2 instructed both mouse and 
human myeloid progenitors to develop into the eosinophil 
lineage (  23  –  25  ). As shown in   Fig. 5 B  , hEoPs possessed 
approximately two- to threefold increased levels of GATA-1 
and GATA-2 as compared with those in hCMPs, whereas 
hGMPs completely shut down these GATA factors. The ex-
pression level of GATA-1 in hEoPs was signifi  cantly lower 
    Figure 4.         hEoPs develop from hCMPs independent of hGMPs and 
hMEPs.   (A). Development of IL-5R    +   hEoPs from IL-5R          hCMPs in liq-
uid culture. (B) The IL-5R    – expressing  cells  purifi  ed from the primary 
hCMP culture formed only eosinophil colonies in the presence of the mul-
tiple cytokines used in   Fig. 2 B  . All single colonies were picked up and 
were mounted on cytospin preparations to defi  ne cell components. 
(C) FACS analyses of cell-surface molecules on the hEoP (continuous line, 
hEoPs; dashed line, blood eosinophils; bold dashed line, control anti-
bodies). Data were reproducible in two independent experiments using 
different bone marrow samples. FSC, forward scatter.     JEM VOL. 206, January 19, 2009 
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the bone marrow of patients with eosinophilia. Thus, like 
mouse hematopoiesis, the developmental pathway initiating 
from the distinct hEoP stage exists in human bone marrow, 
and the hEoP should actively contribute toward generation 
of eosinophils in vivo. 
  We have also developed a method to ultimately purify 
mature neutrophils, eosinophils, and basophils from human 
    DISCUSSION   
  In the present study, we identifi  ed the hEoP in steady-state 
human bone marrow. This population gave rise to eosino-
phils but not neutrophils or basophils in vitro. It possessed the 
eosinophil-specifi  c EPX transcript but did not have the baso-
phil-specifi  c HDC or the neutrophil-specifi  c MPO transcripts. 
Furthermore, the hEoP signifi  cantly expanded in number in 
    Figure 5.         The comparison of lineage-affi  liated gene expression between hEoPs and other myeloid progenitors.   (A) RT-PCR analyses of lineage-
affi  liated genes. (B) Quantitative real-time PCR analyses of lineage-instructive transcription factors (Ba, blood basophils; Eo, blood eosinophils). Data were 
reproducible in three independent analyses using different RNA samples. Data represent means   ±   SEM.     190 IDENTIFICATION OF THE HUMAN EOSINOPHIL PROGENITOR   | Mori et al. 
maturation of hEoPs. In addition, G-CSF, a cytokine that 
promotes neutrophil diff  erentiation, did not aff  ect the fate of 
hEoPs. It corresponds with our fi  nding that hEoPs lack the 
expression of G-CSF receptor transcript (unpublished data). 
These observations collectively suggest that the hEoP is abso-
lutely committed to the eosinophil lineage irrespective of a 
cytokine milieu. 
  Basophils were produced from populations within the IL-
5R           CD34  +  CD38  +   fraction, such as hCMPs and hGMPs, 
as well as the CD34  +  CD38        hHSCs (  Fig. 2 C  ). Therefore, in 
normal human hematopoiesis, the IL-5R      +  CD34  +  CD38  +   
hEoP does not contain progenitors common to eosinophils 
and basophils. It is still unclear at what stage basophils up-
regulate IL-5R    . Because all IL-5R      +  CD34  +  CD38  +   cells 
have committed to the eosinophil lineage, and because hGMPs 
were capable of producing basophils (  Fig. 2 C  ), putative 
hBaP may exist within or downstream of the hGMP popula-
tion. Basophils may up-regulate IL-5R     at a later stage of 
their maturation after cells shut off   CD34 expression. To iso-
late hBaPs, the identifi  cation of new surface antigens that mark 
early basophil lineage commitment is necessary. 
  This study also indicates that the conventional hCMP 
population defi  ned by our earlier work (  15  ) was heteroge-
neous because it contained at least the hEoP. Therefore, we 
should revise our original defi  nition of hCMP: the true hCMP 
(i.e., revised hCMP) resides in the IL-5R            fraction of con-
ventional hCMP (  Fig. 6 B  ). The IL-5R            hCMP gave rise 
to the IL-5R      +   hEoP (  Fig. 4  ), suggesting that the eosinophil 
blood (  Fig. 1 A  ). In contrast to mouse hematopoiesis, where 
IL-5R     is expressed in the eosinophil but not the basophil 
lineage, mature human basophils expressed IL-5R     at a level 
comparable to that of eosinophils (  Fig. 1 A  ). Interestingly, 
the IL-5R      +  CD34  +  CD38  +   population (i.e., hEoP) gave rise 
only to eosinophils and activated the EPX, whereas they did 
not diff  erentiate into basophils or neutrophils nor did they ac-
tivate the HDC or the MPO after culture (  Fig. 3  ). We found 
that the hEoP having the identical IL-5R      +  CD34  +  CD38  +   
phenotype resided also in the umbilical cord blood and in the 
adult peripheral blood. They were extremely rare populations 
(    0.005% of cord blood and 0.001% of blood MNCs, respec-
tively) but diff  erentiated only into eosinophils at a similar effi   -
ciency (unpublished data). Thus, the IL-5R      +  CD34  +  CD38  +   
phenotype is common to the hEoP in multiple locations, in-
cluding the bone marrow, the peripheral blood, and the cord 
blood. hEoPs may emigrate from the bone marrow into circula-
tion and may be recruited into sites of allergic infl  ammation. 
  The expression of IL-5R     in hEoPs might occur as a re-
sult of eosinophil lineage commitment without exerting in-
structive functions for eosinophil lineage specifi  cation. We 
have previously shown that the enforced IL-5 signaling at the 
mGMP stage by transducing mouse IL-5R     induced mainly 
neutrophil/macrophage- but not eosinophil-specifi  c diff  er-
entiation (  4  ). Consistent with this data, hEoPs generated only 
eosinophils even when we removed IL-5 from the cytokine 
cocktail, suggesting that IL-3 and/or GM-CSF signaling is 
suffi   cient to support the survival/proliferation and the terminal 
    Table I.        Percentages of hEoP in normal and eosinophilia bone marrow 
Patient no. Diagnosis Age/sex WBC (/  μ  l) Eosinophils  
  in PB (%)
Eosinophils  
  in BM (%)
hEoP in  
  BMMNCs (%)
hEoP in  
  Lin       CD34  +   (%)
     1 HES 17/M 18,510 12,957 (70) NA 0.227 7.72
     2 HES 50/M 29,530 14,647 (49.6) NA 0.253 6.87
     3 HES 51/M 13,220 4,680 (35.4) 21.2 0.186 3.85
     4 HES 62/F 16,800 9,593 (57.1) 36.4 0.047 12.7
     5 HES 68/M 12,800 3,430 (26.8) 32.8 0.048 4.73
     6 T cell lymphoma 75/F 30,180 27,011 (89.5) 66.8 0.039 11.8
     7 ATL 60/M 57,510 24,442 (42.5) 38 0.056 5.66
     8 CML 48/M 436,000 34,008 (7.8) 9.6 0.33 8.46
     9 AGA 34/F 23,210 14,669 (63.2) 49.6 0.074 5.82
     10 AGA 66/F 40,000 33,240 (83.1) 76.4 0.072 9.91
     11 unknown 81/F 9,300 2,632 (28.3) 36.4 0.043 7.56
     12 unknown 26/F 10,970 5,331 (48.6) 22.4 0.052 3.84
     13 unknown 50/F 13,610 3,062 (22.5) 28.8 0.076 8.67
     14 unknown 57/M 21,020 13,747 (65.4) 37.6 0.207 6.92
     15 unknown 76/M 10,380 3,529 (34) 43.2 0.161 7.09
     Average 57 49,536 13,799 (48.3) 38.4 0.125 7.44
     SD (17  –  81) 107,711 11,026 (23.2) 18.1 0.094 2.61
Normal BM  
  (  n   = 7)
     Average 46 5,164 176 (3.26) 3.09 0.033 2.38
     SD (28  –  72) 1,652 110 (1.21) 1.17 0.013 0.46
AGA, allergic granulomatous angitis; ATL, adult T cell leukemia; BMMNC, bone marrow MNC; CML, chronic myelogenous leukemia; NA, not applicable; PB, peripheral blood.JEM VOL. 206, January 19, 2009 
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granulocyte subclass potentials may reside within the IL-
5R            hCMP fraction (  Fig. 6 B  ). Another possibility is that a 
putative erythroid/eosinophil progenitor that preferentially 
diff  erentiates into the erythroid and the eosinophil lineages 
(  12  ) may exist upstream of the hEoP within the IL-5R            
hCMP fraction independent of the hEoP, hMEP, and hGMP. 
To fully understand the myeloerythroid lineage relationship, 
these possibilities should be tested in future studies. 
  Although the eosinophil developmental pathway could 
be somewhat diff  erent between the human and mouse, the 
use of key transcription factors appeared to be well preserved 
between these species (  Fig. 5  ) (  29  ). The hCMP expressed 
only low levels of GATA-1 and GATA-2 but both were up-
regulated in the hEoP. The expression of C/EBP     was main-
tained, whereas FOG-1 was suppressed in the hEoP. In mouse 
hematopoiesis, we have shown that the order of expression of 
C/EBP     and GATA-2 plays a pivotal role in the eosinophil 
versus the basophil lineage commitment (  29  ). It is of interest 
whether such interplay of transcription factors is also critical 
in human hematopoiesis. 
  In summary, we have identifi  ed the hEoP as an IL-5R      +   
fraction of conventional hCMP. Thus, we propose to revise 
our original defi  nition of hCMP by excluding an IL-5R      +   
fraction from the previous one: the revised phenotype of 
hCMP is IL-5R           Lin       CD34  +  CD38  +  IL-3R      +  CD45RA       . 
The hEoP signifi  cantly expands in patients suff  ering from dis-
eases with eosinophilia, presumably refl  ecting their contribu-
tion toward eosinophil production in vivo. Therefore, this 
population should be useful to study the normal and abnormal 
eosinophil development, and could be a therapeutic target of 
diseases with eosinophila such as HES and allergic disorders. 
  MATERIALS AND METHODS 
  Bone marrow and blood samples.     Bone marrow samples were obtained 
from healthy volunteers (  n   = 7) and eosinophilia patients (  n   = 15) by a con-
ventional bone marrow aspiration procedure. All donors gave informed con-
sent, and the study was approved by the Institutional Review Board of 
Kyushu University Hospital. Patients  ’   characteristics are summarized in 
  Table I  . The diagnosis of HES was made according to the World Health 
Organization criteria. The   FIP1L1/PDGFR       fusion gene, which relates to 
the pathogenesis of chronic eosinophilic leukemia, was analyzed by a nested 
RT-PCR method, as previously described (  33  ). The EoL-1 cell line was 
used as a positive control for the PCR assay. All patients  ’   samples analyzed in 
this study were negative for the   FIP1L1/PDGFR       fusion gene. 
  Antibodies, cell staining, and sorting.     Anti  –  human IL-5R     mono-
clonal antibodies (KM1266) (  34  ) were biotinylated with an EZ-Link 
NHS-PEO  4   Solid Phase Biotinylation Kit (Thermo Fisher Scientifi  c) 
according to the manufacturer  ’  s protocol. To separate mature granulo-
cyte subclasses, heparinized whole blood was stained with biotinylated 
anti  –  IL-5R     antibodies followed by streptavidin-PE (eBioscience) in 
combination with anti-CCR3 (R  &  D Systems), anti-Fc    RI     (eBio-
science), anti-CD203c (Beckman Coulter), or anti  –      7 integrin (BD) 
antibodies.  The sorting procedures for hHSCs and myeloid progenitor 
populations that we previously reported (  15  ) were slightly modifi  ed. In 
brief, bone marrow MNCs obtained by a density-gradient centrifugation 
method were fi  rst stained with PE-Cy5  –  conjugated lineage antibodies, in-
cluding anti-CD3, -CD4, -CD8, -CD10, -CD19, -CD20, -CD14, -CD56, 
and   –  glycophorin A. Subsequently, cells were stained with allophycocya-
nin-conjugated anti-CD34 (BD), PE-conjugated anti-CD38 (Invitrogen), 
lineage commitment occurs at least within the IL-5R            
hCMP stage. However, we cannot exclude the possibility 
that a portion of hEoPs develop directly from the earlier pro-
genitors such as hHSCs and hMPPs, bypassing the hCMP 
stage. The hGMP does not faithfully correspond to the 
mGMP because the hGMP lacked the eosinophil potential 
(  Fig. 2  ), whereas the mGMP was capable of producing all 
granulocyte subclasses, including eosinophils and basophils via 
their progenitor populations such as the mEoP and the mBaP. 
Therefore, it is also possible that the true hGMP with all 
    Figure 6.         The in vivo expansion of hEoP in the bone marrow of 
eosinophilia patients.   (A) The percentage of the hEoP population in the 
bone marrow CD34  +   fraction. Eosinophila patients possessed approximately 
fourfold increased numbers of hEoPs (horizontal lines indicate means). 
Patients  ’   characteristics are summarized in   Table I  . (B) The lineal relationship 
between the hEoP and other myeloid progenitor populations. The original 
hCMP (shaded) contained the hEoP. The revised hCMP is defi  ned as the 
IL-5R          fraction of the original hCMP. The hEoP develops from the hCMP 
or its upstream MPP independent of the hGMP and the hMEP.     192 IDENTIFICATION OF THE HUMAN EOSINOPHIL PROGENITOR   | Mori et al. 
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PE-Cy7  –  conjugated anti  –  IL-3R     (eBioscience), and FITC-conjugated anti-
CD45RA (eBioscience) antibodies. hHSCs, hCMPs, hGMPs, and hMEPs 
were isolated as Lin       CD34  +  CD38       , Lin       CD34  +  CD38  +  IL-3R      +  CD45RA       , 
Lin       CD34  +  CD38  +  IL-3R      +  CD45RA  +  , and Lin       CD34  +  CD38  +  IL-3R            
CD45RA        populations, respectively. To sort hEoPs and redefi  ned hCMPs, 
Pacifi  c  blue  –  conjugated anti-CD38 antibodies were used, and biotinylated 
anti  –  IL-5R     antibodies followed by streptavidin-PE were added. hEoPs 
and hCMPs were purified as Lin       CD34  +  CD38  +  IL-3R      +  CD45RA       IL-
5R      +   and Lin       CD34  +  CD38  +  IL-3R      +  CD45RA       IL-5R            populations, 
respectively. Dead cells were excluded by propidium iodide staining. 
Appropriate isotype-matched control monoclonal antibodies were used 
to determine the background staining level in each channel. All sorting 
and analyses were performed on three laser-equipped FACSAria machines 
(BD). To minimize contamination, the second round of sorting was per-
formed routinely with the same sorting gates as the fi  rst round. The au-
tomatic cell-deposition system was used for single-cell assays. FACS data 
were analyzed with FlowJo software (Tree Star, Inc.). 
  Cell culture.     For liquid cultures, purifi  ed progenitor populations were sus-
pended in 12-well plates with the following medium: IMDM (Invitrogen) 
supplemented with 20% FCS (StemCell Technologies Inc.), antibiotics, 
20 ng/ml of human recombinant IL-3, 20 ng/ml IL-5, 20 ng/ml SCF, 
50 ng/ml GM-CSF, 4 U/ml Epo, and 20 ng/ml Tpo (R  &  D Systems). For 
clonogenic analyses of hHSCs and myeloid progenitors, including hEoPs, 
cells were cultured 14 d in IMDM-based methylcellulose medium (Metho-
cult H4100; StemCell Technologies Inc.) with 20% FCS, 1% BSA, 2 mM 
  l  -glutamine, and 50   μ  M 2-mercaptoethanol (StemCell Technologies Inc.). 
The same cytokines described were added at the initiation of cultures. All 
cultures were incubated at 37  °  C in a humidifi  ed chamber under 5% CO  2  . 
All single colonies were picked up and were mounted on cytospin prepara-
tions to defi  ne cell components. 
  Gene expression analysis.     Total RNA was extracted from purifi  ed pro-
genitor populations, cultured cells, or mature blood granulocytes using 
ISOGEN reagent (Nippon Gene) according to the manufacturer  ’  s protocol. 
All RNA samples were reverse transcribed with Oligo dT primers using the 
SuperScript III First-Strand Synthesis System (Invitrogen). The conventional 
RT-PCR and the quantitative real-time PCR assays were performed with 
the GeneAmp 9700 PCR System and the PRISM 7500 Fast Real-Time 
PCR System, respectively (Applied Biosystems). The specifi  c primer and 
probe sequences for PCR analyses are provided in Table S1 (available at 
http://www.jem.org/cgi/content/full/jem.20081756/DC1). Human     2 
microglobulin transcript was simultaneously amplifi  ed as an internal standard 
for quantifi  cation. 
  Online supplemental material.    The specifi  c primer and probe sequences for 
PCR analyses are listed in Table S1. Online supplemental material is available 
at available at http://www.jem.org/cgi/content/full/jem.20081756/DC1. 
  This work was supported in part by the Japanese Ministry of Education, Culture, 
Sports, Science and Technology (grant 18604006 to H. Iwasaki, and grants 17109010 
and 17047029 to K. Akashi), the Takeda Science Foundation, and the Mochida 
Memorial Foundation for Medical and Pharmaceutical Research. 
  The authors have no confl  icting fi  nancial interests. 
Submitted:   7 August 2008 
Accepted:   1 December 2008 
  REFERENCES 
       1  .   Rothenberg  ,   M.E.  , and   S.P.     Hogan  .   2006  .   The eosinophil.       Annu. Rev. 
Immunol.       24  :  147    –    174  .    
       2  .   Rothenberg  ,   M.E.  ,   A.     Mishra  ,   E.B.     Brandt  , and   S.P.     Hogan  .   2001  . 
  Gastrointestinal eosinophils.       Immunol. Rev.       179  :  139    –    155  .    
       3  .   Venge  ,   P.     2004  .   Monitoring the allergic infl  ammation.       Allergy      .     59  :  26    –    32  .    
       4  .   Iwasaki  ,   H.  ,   S.     Mizuno  ,   R.     Mayfi  eld  ,   H.     Shigematsu  ,   Y.     Arinobu  ,   B.   
  Seed  ,   M.F.     Gurish  ,   K.     Takatsu  , and   K.     Akashi  .   2005  .   Identifi  cation of JEM VOL. 206, January 19, 2009 
ARTICLE
193
        24  .   Heyworth  ,   C.  ,   S.     Pearson  ,   G.     May  , and   T.     Enver  .   2002  .   Transcription 
factor-mediated lineage switching reveals plasticity in primary commit-
ted progenitor cells.       EMBO J.       21  :  3770    –    3781  .    
      25  .   Iwasaki  ,   H.  ,   S.     Mizuno  ,   R.A.     Wells  ,   A.B.     Cantor  ,   S.     Watanabe  , and   K.   
  Akashi  .   2003  .   GATA-1 converts lymphoid and myelomonocytic progeni-
tors into the megakaryocyte/erythrocyte lineages.       Immunity      .     19  :  451    –    462  .    
        26  .   Tsang  ,   A.P.  ,   J.E.     Visvader  ,   C.A.     Turner  ,   Y.     Fujiwara  ,   C.     Yu  ,   M.J.   
  Weiss  ,   M.     Crossley  , and   S.H.     Orkin  .   1997  .   FOG, a multitype zinc fi  n-
ger protein, acts as a cofactor for transcription factor GATA-1 in ery-
throid and megakaryocytic diff  erentiation.       Cell      .     90  :  109    –    119  .    
        27  .   Tsang  ,   A.P.  ,   Y.     Fujiwara  ,   D.B.     Hom  , and   S.H.     Orkin  .   1998  .   Failure 
of megakaryopoiesis and arrested erythropoiesis in mice lacking the 
GATA-1 transcriptional cofactor FOG.       Genes Dev.       12  :  1176    –    1188  .    
        28  .   Querfurth  ,   E.  ,   M.     Schuster  ,   H.     Kulessa  ,   J.D.     Crispino  ,   G.     Doderlein  , 
  S.H.     Orkin  ,   T.     Graf  , and   C.     Nerlov  .   2000  .   Antagonism between C/
EBPbeta and FOG in eosinophil lineage commitment of multipotent 
hematopoietic progenitors.       Genes Dev.       14  :  2515    –    2525  .    
        29  .   Iwasaki  ,  H.  ,  S.    Mizuno  ,  Y.    Arinobu  ,  H.    Ozawa  ,  Y.    Mori  ,  H.    Shigematsu  , 
  K.     Takatsu  ,   D.G.     Tenen  , and   K.     Akashi  .   2006  .   The order of expression 
of transcription factors directs hierarchical specifi  cation of hematopoi-
etic lineages.       Genes Dev.       20  :  3010    –    3021  .    
        30  .   Zhang  ,   D.E.  ,   P.     Zhang  ,   N.D.     Wang  ,   C.J.     Hetherington  ,   G.J.   
  Darlington  , and   D.G.     Tenen  .   1997  .   Absence of granulocyte colony-
stimulating factor signaling and neutrophil development in CCAAT 
enhancer binding protein alpha-defi  cient mice.       Proc. Natl. Acad. Sci. 
USA      .     94  :  569    –    574  .    
        31  .   Dakic  ,   A.  ,   D.     Metcalf  ,   L.     Di Rago  ,   S.     Mifsud  ,   L.     Wu  , and   S.L.     Nutt  . 
  2005  .   PU.1 regulates the commitment of adult hematopoietic progeni-
tors and restricts granulopoiesis.       J. Exp. Med.       201  :  1487    –    1502  .    
        32  .   Iwasaki  ,   H.  ,   C.     Somoza  ,   H.     Shigematsu  ,   E.A.     Duprez  ,   J.     Iwasaki-Arai  , 
  S.     Mizuno  ,   Y.     Arinobu  ,   K.     Geary  ,   P.     Zhang  ,   T.     Dayaram  ,   et al  .   2005  . 
  Distinctive and indispensable roles of PU.1 in maintenance of hemato-
poietic stem cells and their diff  erentiation.       Blood      .     106  :  1590    –    1600  .    
        33  .   Cools  ,   J.  ,   D.J.     DeAngelo  ,   J.     Gotlib  ,   E.H.     Stover  ,   R.D.     Legare  ,   J.     Cortes  , 
  J.     Kutok  ,   J.     Clark  ,   I.     Galinsky  ,   J.D.     Griffi   n  ,   et al  .   2003  .   A tyrosine kinase 
created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic 
target of imatinib in idiopathic hypereosinophilic syndrome.       N. Engl. J. 
Med.       348  :  1201    –    1214  .    
        34  .   Ogata  ,   N.  ,   T.     Kouro  ,   A.     Yamada  ,   M.     Koike  ,   N.     Hanai  ,   T.     Ishikawa  , 
and   K.     Takatsu  .   1998  .   JAK2 and JAK1 constitutively associate with an 
interleukin-5 (IL-5) receptor alpha and betac subunit, respectively, and 
are activated upon IL-5 stimulation.       Blood      .     91  :  2264    –    2271  .                     